Mendelian Randomization Unveils Drug Targets for IgA Nephropathy

1Division of Nephrology, Department of Medicine, Columbia University, New York, New York 2Unit of Genomic Variability and Complex Diseases, Department of Medical Sciences, University of Turin, Turin, Italy Correspondence: Dr. Simone Sanna-Cherchi, email: [email protected] See related article, "Circulating Proteins and IgA Nephropathy: A Multiancestry Proteome-Wide Mendelian Randomization Study," on pages 1045–1057.